验证数据展示
经过测试的应用
Positive WB detected in | A431 cells, A431 cell, A549 cell |
推荐稀释比
应用 | 推荐稀释比 |
---|---|
Western Blot (WB) | WB : 1:1000-1:4000 |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, Check data in validation data gallery. |
产品信息
31840-1-AP targets TATDN1 in WB, ELISA applications and shows reactivity with human samples.
经测试应用 | WB, ELISA Application Description |
经测试反应性 | human |
免疫原 | TATDN1 fusion protein Ag36040 种属同源性预测 |
宿主/亚型 | Rabbit / IgG |
抗体类别 | Polyclonal |
产品类型 | Antibody |
全称 | TatD DNase domain containing 1 |
别名 | TatD DNase Domain Containing 1 , Deoxyribonuclease TATDN1, CDA11 |
观测分子量 | 30 kDa |
GenBank蛋白编号 | BC064964 |
基因名称 | TATDN1 |
Gene ID (NCBI) | 83940 |
RRID | AB_3670124 |
偶联类型 | Unconjugated |
形式 | Liquid |
纯化方式 | Antigen affinity Purification |
UNIPROT ID | Q6P1N9 |
储存缓冲液 | PBS with 0.02% sodium azide and 50% glycerol , pH 7.3 |
储存条件 | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. |
背景介绍
Homo sapiens TatD DNase domain containing 1 (TATDN1), a member of the TATD family, is a highly conserved nuclease in both prokaryotes and eukaryotes with depurine/apyrimidine (AP) endonuclease activity, which plays an extremely important role in the genesis and prognosis of malignant tumors such as NSCLC and breast cancer, and is a potential therapeutic target for NSCLC patients who have failed to undergo cisplatin therapy (DDP) in vivo.
实验方案
Product Specific Protocols | |
---|---|
WB protocol for TATDN1 antibody 31840-1-AP | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |